{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Glycosylation : Questions médicales les plus fréquentes",
"headline": "Glycosylation : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Glycosylation : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-05-04",
"dateModified": "2025-04-29",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Glycosylation"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Métabolisme glucidique",
"url": "https://questionsmedicales.fr/mesh/D050260",
"about": {
"@type": "MedicalCondition",
"name": "Métabolisme glucidique",
"code": {
"@type": "MedicalCode",
"code": "D050260",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "G03.191"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Glycosylation",
"alternateName": "Glycosylation",
"code": {
"@type": "MedicalCode",
"code": "D006031",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Christian Marcus Pedersen",
"url": "https://questionsmedicales.fr/author/Christian%20Marcus%20Pedersen",
"affiliation": {
"@type": "Organization",
"name": "Department of Chemistry, University of Copenhagen, Universitetsparken 5, 2100 Copenhagen Ø, Denmark."
}
},
{
"@type": "Person",
"name": "Yanjing Li",
"url": "https://questionsmedicales.fr/author/Yanjing%20Li",
"affiliation": {
"@type": "Organization",
"name": "Department of Emergency, State Key Laboratory of Biotherapy, West China Hospital, and School of Chemical Engineering, Sichuan University, No. 17 Renmin Nan Road, Chengdu, 610041, China."
}
},
{
"@type": "Person",
"name": "Dawen Niu",
"url": "https://questionsmedicales.fr/author/Dawen%20Niu",
"affiliation": {
"@type": "Organization",
"name": "Department of Emergency, State Key Laboratory of Biotherapy, West China Hospital, and School of Chemical Engineering, Sichuan University, No. 17 Renmin Nan Road, Chengdu, 610041, China."
}
},
{
"@type": "Person",
"name": "Liang Yang",
"url": "https://questionsmedicales.fr/author/Liang%20Yang",
"affiliation": {
"@type": "Organization",
"name": "Department of Chemistry, University of Copenhagen, Universitetsparken 5, 2100 Copenhagen Ø, Denmark."
}
},
{
"@type": "Person",
"name": "Boon Chong Lee",
"url": "https://questionsmedicales.fr/author/Boon%20Chong%20Lee",
"affiliation": {
"@type": "Organization",
"name": "Department of Chemistry, National University of Singapore, 4 Science Drive 2, Singapore, 117544, Republic of Singapore."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "The Social Shapes Test as a Self-Administered, Online Measure of Social Intelligence: Two Studies with Typically Developing Adults and Adults with Autism Spectrum Disorder.",
"datePublished": "2023-02-09",
"url": "https://questionsmedicales.fr/article/36757539",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s10803-023-05901-2"
}
},
{
"@type": "ScholarlyArticle",
"name": "Successful treatment of rituximab-unresponsive elderly-onset neuromyelitis optica spectrum disorder and hypogammaglobulinemia with ofatumumab plus intravenous immunoglobulin therapy in a patient with mutant",
"datePublished": "2022-12-08",
"url": "https://questionsmedicales.fr/article/36569904",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3389/fimmu.2022.1047992"
}
},
{
"@type": "ScholarlyArticle",
"name": "The different damage patterns of short-, middle- and long-range connections between patients with relapse-remitting multiple sclerosis and neuromyelitis optica spectrum disorder.",
"datePublished": "2022-12-02",
"url": "https://questionsmedicales.fr/article/36532033",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3389/fimmu.2022.1007335"
}
},
{
"@type": "ScholarlyArticle",
"name": "Histomorphological Spectrum and Diagnostic Challenges in Thymic Epithelial Neoplasms with their Prognostic Significance: A Case Series of 33 Cases at a Regional Cancer Center in Western India.",
"datePublished": "2022-12-02",
"url": "https://questionsmedicales.fr/article/39410987",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1055/s-0042-1757556"
}
},
{
"@type": "ScholarlyArticle",
"name": "Rational Development of Hypervalent Glycan Shield-Binding Nanoparticles with Broad-Spectrum Inhibition against Fatal Viruses Including SARS-CoV-2 Variants.",
"datePublished": "2022-11-15",
"url": "https://questionsmedicales.fr/article/36377484",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1002/advs.202202689"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Métabolisme",
"item": "https://questionsmedicales.fr/mesh/D008660"
},
{
"@type": "ListItem",
"position": 3,
"name": "Métabolisme glucidique",
"item": "https://questionsmedicales.fr/mesh/D050260"
},
{
"@type": "ListItem",
"position": 4,
"name": "Glycosylation",
"item": "https://questionsmedicales.fr/mesh/D006031"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Glycosylation - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Glycosylation",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-08",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Glycosylation",
"description": "Comment diagnostiquer une anomalie de glycosylation ?\nQuels tests sanguins sont utilisés pour la glycosylation ?\nLes biopsies sont-elles utiles pour la glycosylation ?\nQuels symptômes indiquent une anomalie de glycosylation ?\nPeut-on utiliser l'imagerie pour diagnostiquer la glycosylation ?",
"url": "https://questionsmedicales.fr/mesh/D006031?mesh_terms=Spectrum+Analysis&page=1000#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Glycosylation",
"description": "Quels sont les symptômes d'une glycosylation anormale ?\nLa fatigue est-elle un symptôme de glycosylation ?\nLes troubles digestifs sont-ils liés à la glycosylation ?\nY a-t-il des symptômes cutanés associés ?\nLes problèmes de croissance sont-ils fréquents ?",
"url": "https://questionsmedicales.fr/mesh/D006031?mesh_terms=Spectrum+Analysis&page=1000#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Glycosylation",
"description": "Peut-on prévenir les anomalies de glycosylation ?\nLe dépistage génétique est-il recommandé ?\nLes vaccinations aident-elles à prévenir les complications ?\nY a-t-il des conseils diététiques préventifs ?\nLes consultations médicales régulières sont-elles importantes ?",
"url": "https://questionsmedicales.fr/mesh/D006031?mesh_terms=Spectrum+Analysis&page=1000#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Glycosylation",
"description": "Quels traitements existent pour les anomalies de glycosylation ?\nLes enzymes de remplacement sont-elles efficaces ?\nLa diététique joue-t-elle un rôle dans le traitement ?\nLes médicaments immunosuppresseurs sont-ils utilisés ?\nY a-t-il des traitements expérimentaux disponibles ?",
"url": "https://questionsmedicales.fr/mesh/D006031?mesh_terms=Spectrum+Analysis&page=1000#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Glycosylation",
"description": "Quelles sont les complications possibles de la glycosylation ?\nLes infections sont-elles fréquentes chez ces patients ?\nY a-t-il des risques de cancer associés ?\nLes troubles cardiovasculaires sont-ils liés ?\nLes complications psychologiques sont-elles possibles ?",
"url": "https://questionsmedicales.fr/mesh/D006031?mesh_terms=Spectrum+Analysis&page=1000#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Glycosylation",
"description": "Quels sont les facteurs de risque pour les anomalies de glycosylation ?\nL'âge joue-t-il un rôle dans la glycosylation ?\nLes facteurs environnementaux influencent-ils la glycosylation ?\nLes maladies métaboliques augmentent-elles le risque ?\nLe sexe a-t-il un impact sur la glycosylation ?",
"url": "https://questionsmedicales.fr/mesh/D006031?mesh_terms=Spectrum+Analysis&page=1000#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une anomalie de glycosylation ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests génétiques et des analyses de glycoprotéines sont utilisés."
}
},
{
"@type": "Question",
"name": "Quels tests sanguins sont utilisés pour la glycosylation ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les tests de glycoprotéines et les profils glycosylés sont courants."
}
},
{
"@type": "Question",
"name": "Les biopsies sont-elles utiles pour la glycosylation ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les biopsies tissulaires peuvent révéler des anomalies de glycosylation."
}
},
{
"@type": "Question",
"name": "Quels symptômes indiquent une anomalie de glycosylation ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des retards de développement, des problèmes immunitaires et des anomalies neurologiques."
}
},
{
"@type": "Question",
"name": "Peut-on utiliser l'imagerie pour diagnostiquer la glycosylation ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'imagerie n'est pas spécifique, mais peut aider à évaluer des complications."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes d'une glycosylation anormale ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent des troubles neurologiques, des infections fréquentes et des anomalies physiques."
}
},
{
"@type": "Question",
"name": "La fatigue est-elle un symptôme de glycosylation ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la fatigue peut être un symptôme associé à des troubles de glycosylation."
}
},
{
"@type": "Question",
"name": "Les troubles digestifs sont-ils liés à la glycosylation ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certains troubles digestifs peuvent être liés à des anomalies de glycosylation."
}
},
{
"@type": "Question",
"name": "Y a-t-il des symptômes cutanés associés ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des éruptions cutanées et des anomalies de la peau peuvent survenir."
}
},
{
"@type": "Question",
"name": "Les problèmes de croissance sont-ils fréquents ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des retards de croissance peuvent être observés chez les patients affectés."
}
},
{
"@type": "Question",
"name": "Peut-on prévenir les anomalies de glycosylation ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "La prévention est difficile, mais un diagnostic précoce peut aider à gérer les symptômes."
}
},
{
"@type": "Question",
"name": "Le dépistage génétique est-il recommandé ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le dépistage génétique peut être utile pour les familles à risque."
}
},
{
"@type": "Question",
"name": "Les vaccinations aident-elles à prévenir les complications ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les vaccinations peuvent réduire le risque d'infections chez ces patients."
}
},
{
"@type": "Question",
"name": "Y a-t-il des conseils diététiques préventifs ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une alimentation équilibrée peut soutenir la santé globale et le système immunitaire."
}
},
{
"@type": "Question",
"name": "Les consultations médicales régulières sont-elles importantes ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elles permettent de surveiller l'évolution et d'ajuster les traitements."
}
},
{
"@type": "Question",
"name": "Quels traitements existent pour les anomalies de glycosylation ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les traitements incluent des thérapies de soutien et des interventions spécifiques selon les symptômes."
}
},
{
"@type": "Question",
"name": "Les enzymes de remplacement sont-elles efficaces ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elles peuvent être efficaces pour certaines formes de maladies liées à la glycosylation."
}
},
{
"@type": "Question",
"name": "La diététique joue-t-elle un rôle dans le traitement ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des régimes spécifiques peuvent aider à gérer certains symptômes."
}
},
{
"@type": "Question",
"name": "Les médicaments immunosuppresseurs sont-ils utilisés ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Ils peuvent être prescrits pour traiter des complications immunitaires."
}
},
{
"@type": "Question",
"name": "Y a-t-il des traitements expérimentaux disponibles ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des essais cliniques sont en cours pour de nouvelles thérapies ciblées."
}
},
{
"@type": "Question",
"name": "Quelles sont les complications possibles de la glycosylation ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent des troubles neurologiques, des infections et des problèmes de croissance."
}
},
{
"@type": "Question",
"name": "Les infections sont-elles fréquentes chez ces patients ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les patients peuvent être plus susceptibles aux infections en raison d'un système immunitaire affaibli."
}
},
{
"@type": "Question",
"name": "Y a-t-il des risques de cancer associés ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines anomalies de glycosylation peuvent augmenter le risque de cancers spécifiques."
}
},
{
"@type": "Question",
"name": "Les troubles cardiovasculaires sont-ils liés ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des troubles cardiovasculaires peuvent survenir chez certains patients."
}
},
{
"@type": "Question",
"name": "Les complications psychologiques sont-elles possibles ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des complications psychologiques comme l'anxiété peuvent être observées."
}
},
{
"@type": "Question",
"name": "Quels sont les facteurs de risque pour les anomalies de glycosylation ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les antécédents familiaux et certaines mutations génétiques sont des facteurs de risque."
}
},
{
"@type": "Question",
"name": "L'âge joue-t-il un rôle dans la glycosylation ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines anomalies peuvent se manifester plus tôt dans l'enfance, mais d'autres plus tard."
}
},
{
"@type": "Question",
"name": "Les facteurs environnementaux influencent-ils la glycosylation ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des facteurs environnementaux peuvent interagir avec des prédispositions génétiques."
}
},
{
"@type": "Question",
"name": "Les maladies métaboliques augmentent-elles le risque ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines maladies métaboliques peuvent être associées à des anomalies de glycosylation."
}
},
{
"@type": "Question",
"name": "Le sexe a-t-il un impact sur la glycosylation ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certaines anomalies peuvent avoir des manifestations différentes selon le sexe."
}
}
]
}
]
}
The Social Shapes Test (SST) is a measure of social intelligence which does not use human faces or rely on extensive verbal ability. The SST has shown promising validity among adults without autism sp...
Elderly-onset neuromyelitis optica spectrum disorder (NMOSD) is a rare entity that poses a therapeutic challenge. We report a case of elderly-onset NMOSD with mutant...
The patient was a 67-year-old woman who was diagnosed with NMOSD with high disease activity. She experienced six episodes of relapse over a period of 2 years despite immunosuppressant therapy with int...
Ofatumumab might be an effective alternative in RTX-unresponsive NMOSD, and seems to be safe in elderly patients....
To investigate the differences in short-, middle- and long-range connections between patients with relapse-remitting multiple sclerosis (RRMS) and neuromyelitis optica spectrum disorder (NMOSD), and t...
A total of 51 RRMS, 42 NMOSD and 56 health controls (HC) were recruited. Of these 25 RRMS (median: 1.37 years) and 20 NMOSD (median: 1.25 years) patients were also studied at follow-up. The whole-brai...
Compared to HC and NMOSD, the total number of fibers in RRMS was decreased, including the reduced FN of middle- and long-range connections, but increased FN of short-range connections. Compared to HC,...
RRMS and NMOSD patients have different patterns of fiber connection damage. The FN of different lengths in RRMS and NMOSD patients may be associated with brain atrophy. The FN and FA of different leng...
Infectious virus diseases, particularly coronavirus disease 2019, have posed a severe threat to public health, whereas the developed therapeutic and prophylactic strategies are seriously challenged by...
Abnormal placentation is a spectrum disorder that includes creta, increta, and percreta; the term placenta accreta spectrum (PAS) disorders is used as a broad term to describe all of these conditions....
This retrospective cohort study was conducted at a comprehensive tertiary hospital in Chongqing, China, between January 2018 and December 2020. The target independent and dependent variables were CL a...
In total, 317 participants were enrolled, in whom the prevalence of massive bleeding was 41.9% (133/317). The threshold of CL associated with massive bleeding (≥1,000 ml) was 33 mm based on a receiver...
CL was negatively associated with massive intraoperative bleeding in patients with PAS combined with placenta previa. When the CL was greater than 33 mm, the risk of bleeding decreased by 44%. Thus, C...
Technology offers educators tools that can tailor learning to students' learning styles and interests. Research into the use of socially-assistive robots as a learning support for children on the auti...
Social functioning deficits during adolescence are associated with later psychiatric morbidity, particularly in offspring at high genetic risk for schizophrenia spectrum disorders. However, a shortcom...
Papillary renal neoplasm with reverse polarity (PRNRP) is a recently described, rare renal tumor that differs clinically, morphologically, and molecularly from papillary renal cell carcinoma (RCC). To...
Time-resolved fluorescence (TF) with high-enough resolution enables recording of a coherent vibrational spectrum (CVS). Because a CVS attained via TF (CVSF) is descended from the frequency modulation ...